openPR Logo
Press release

Dysmenorrhea Treatment Market Value Projected to Expand by 2028

12-23-2022 06:29 AM CET | Health & Medicine

Press release from: Orion Market Research

Dysmenorrhea Treatment Market Value Projected to Expand by 2028

Dysmenorrhea Treatment Market is anticipated to grow at a considerable CAGR of 8.1% during the forecast period (2022-2028). Dysmenorrhea is a common gynaecological condition that affects women of all ages and races. It is one of the most commonly diagnosed causes of pelvic pain in women. The symptoms associated with dysmenorrhea include gastrointestinal symptoms such as diarrhoea, nausea, bloating, constipation, or both, along with vomiting and indigestion. According to the National Centre for Biotechnology Information the prevalence of dysmenorrhea can vary between 16% and 91% in women of reproductive age, with severe pain observed in 2% to 29%. Dysmenorrhea is associated with significant impairment in quality of life between 16% to 29% of women. Furthermore, 12% of the monthly school and work activities are lost due to absenteeism because of dysmenorrhea. 

To Request a Sample of our Report on Dysmenorrhea Treatment Market:  https://www.omrglobal.com/request-sample/dysmenorrhea-treatment-market

Rising acquisitions, product approval, collaborations among the major players in the market also propel the growth of the market. For instance, in May 2020, Mochida Pharmaceutical Co., Ltd announced the launch of DINAGEST Tablets 0.5 mg a therapeutic agent for dysmenorrhea. DINAGEST Tablets 1 mg, a therapeutic agent for endometriosis, was licensed from Jenapharm, a subsidiary of Bayer AG, and developed by Mochida. The drug is marketed in Japan since 2008 and an additional indication, reduction of pain caused by adenomyosis. 

Market Coverage

The market number available for - 2021-2028
Base year- 2021
Forecast period- 2022-2028

Segment Covered- 

By Treatment Type
By Type

Regions Covered

North America
Europe
Asia-Pacific
Rest of the World

Competitive Landscape- Novartis AG, Bayer AG, Abbott Laboratories, F. Hoffmann-La Roche Ltd. 

A full Report of Dysmenorrhea Treatment Market is Available @ https://www.omrglobal.com/industry-reports/dysmenorrhea-treatment-market

Dysmenorrhea Treatment Market Report by Segment

By Treatment Type.

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Hormonal Therapy 

By Type 

Primary Dysmenorrhea
Secondary Dysmenorrhea 

Dysmenorrhea Treatment Market Report by Region

North America

United States
Canada

Europe

UK
Germany
Spain
France
Italy
Rest of Europe

Asia-Pacific

India
China
Japan
South Korea
Rest of APAC

Rest of the World

Latin America 
Middle East & Africa

Company Profiles 

Bayer AG
Hoffmann-La Roche Ltd
SANOFI
Alvogen Iceland
Pfizer Inc.
ObsEva
Nobelpharma Co., Ltd
Color Seven Co., Ltd.
Sun Pharmaceutical Industries Limited
Beurer GmbH
Abbott Laboratories
Taj Pharmaceuticals Ltd
Myovant Sciences GmbH
AbbVie Inc.
Janssen Pharmaceuticals, Inc. 
At Lupin Inc.
Cumberland Pharmaceuticals Inc.
BioElectronics Corporation
GlaxoSmithKline plc.
Merck & Co., Inc.

Reasons to buy from us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

https://sportmsr.com/%d9%85%d9%86-%d8%a7%d9%84%d9%85%d8%aa%d9%88%d9%82%d8%b9-%d8%a3%d9%86-%d8%aa%d8%aa%d9%88%d8%b3%d8%b9-%d8%a7%d9%84%d9%82%d9%8a%d9%85%d8%a9-%d8%a7%d9%84%d8%b3%d9%88%d9%82%d9%8a%d8%a9-%d9%84%d9%84%d9%8a-2/
https://revistaeconomiasocial.com/2022/12/22/el-mercado-europeo-de-inhaladores-preventivos-sera-testigo-de-una-aceleracion-del-crecimiento-para-2028/
https://www.diario-ya.com/regionales/%e9%a0%90%e8%a8%88%e5%88%b0-2022-2028-%e5%b9%b4%e5%be%b7%e5%9c%8b%e9%a0%90%e9%98%b2%e6%80%a7%e5%90%b8%e5%85%a5%e5%99%a8%e5%b8%82%e5%a0%b4%e5%a2%9e%e9%95%b7%e7%8e%87%e4%bd%8e%e8%bf%b7/272806/
https://citytoday-hildesheim.de/index.php/2022/12/22/der-nordamerikanische-markt-fur-praventive-inhalatoren-soll-bis-2028-schnell-wachsen/
https://www.asiatimeskorea.com/news/2028%eb%85%84%ea%b9%8c%ec%a7%80-%ea%b8%89%ec%86%8d%ed%95%9c-%ec%84%b1%ec%9e%a5%ec%9d%84-%eb%b3%bc-%ec%98%81%ea%b5%ad-%ec%98%88%eb%b0%a9-%ed%9d%a1%ec%9e%85%ea%b8%b0-%ec%8b%9c%ec%9e%a5/195120/

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

About Orion Market Research 
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dysmenorrhea Treatment Market Value Projected to Expand by 2028 here

News-ID: 2860643 • Views:

More Releases from Orion Market Research

North American Cardiovascular Devices Market to Witness Growth Acceleration by 2031
North American Cardiovascular Devices Market to Witness Growth Acceleration by 2 …
North American cardiovascular devices market is projected to grow at a significant CAGR of 5.6% during the forecast period. The market growth in North America can be attributed to the rising geriatric population, frequent US FDA approvals for innovative cardiovascular devices, and the growing adoption of minimally invasive/non-invasive cardiac surgeries. There are several cardiac health organizations working in the US, such as American Heart Association. The geriatric population is more
Topical Drug Delivery Market Will Exhibit an Impressive Expansion by 2024-2031
Topical Drug Delivery Market Will Exhibit an Impressive Expansion by 2024-2031
The global topical drug delivery market is anticipated to grow at a considerable CAGR of 6.1% during the forecast period. The key factor contributing to the market growth includes the increasing approvals, grants, and clearance by government authorities and regulatory bodies for topical drugs. For instance, • In July 2022, Alembic Pharmaceuticals, (Aleor Dermaceuticals) received the US Food and Drug Administration (US FDA) approval for its Abbreviated New Drug Application (ANDA) for
Surgical Retractors Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
Surgical Retractors Market Size, Trends, Latest Insights, Analysis and Forecast …
The global surgical retractors market is anticipated to grow at a considerable CAGR of 6.3% during the forecast period. The increasing research and development activities for the development of new and advanced medical devices by the pharmaceutical and biotechnology companies. Increasing demand for the new surgical devices by the end-users are key factors that are contributing to the growth of the surgical retractors market. For instance, • In June 2022, U.S.
Medical Packaging Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
Medical Packaging Market Size, Trends, Latest Insights, Analysis and Forecast 20 …
The global medical packaging market is anticipated to grow with a significant CAGR of 6.1% during the forecast period. The growth of the medical packaging market is attributed to the rapidly changing healthcare industry. The medical packaging market is continuously experiencing various changes owing to the outbreak of new diseases, increasing regulatory norms, and growth in advanced healthcare systems. Furthermore, increasing development in diagnostics, pathological and other allied medical equipment

All 5 Releases


More Releases for Dysmenorrhea

Dysmenorrhea Treatment Market: Market Intelligence and Market Trends
Dysmenorrhea is a medical terminology used for menstrual pains in which the female encounters severe cramps in her lower abdomen which may extend to the lower legs and back. Most women begin having dysmenorrhea during adolescence, usually within four to five years of first menstrual period. Prostaglandins are chemicals that are formed in the lining of the uterus during menstruation. These prostaglandins cause muscle contractions in the uterus, which cause
Trends in the Dysmenorrhea Treatment Market 2016 - 2026
Dysmenorrhea is a medical terminology used for menstrual pains in which the female encounters severe cramps in her lower abdomen which may extend to the lower legs and back. Most women begin having dysmenorrhea during adolescence, usually within four to five years of first menstrual period. Prostaglandins are chemicals that are formed in the lining of the uterus during menstruation. These prostaglandins cause muscle contractions in the uterus, which cause
Dysmenorrhea Treatment Market Intelligence Research Reports for Actionable Insig …
Dysmenorrhea is a medical terminology used for menstrual pains in which the female encounters severe cramps in her lower abdomen which may extend to the lower legs and back. Most women begin having dysmenorrhea during adolescence, usually within four to five years of first menstrual period. Prostaglandins are chemicals that are formed in the lining of the uterus during menstruation. These prostaglandins cause muscle contractions in the uterus, which cause
Trends in the Dysmenorrhea Treatment Market 2016 - 2026
Dysmenorrhea is a medical terminology used for menstrual pains in which the female encounters severe cramps in her lower abdomen which may extend to the lower legs and back. Most women begin having dysmenorrhea during adolescence, usually within four to five years of first menstrual period. Prostaglandins are chemicals that are formed in the lining of the uterus during menstruation. These prostaglandins cause muscle contractions in the uterus, which cause
Dysmenorrhea Treatment Market Insights and Analysis for Period 2016-2026
Dysmenorrhea is a medical terminology used for menstrual pains in which the female encounters severe cramps in her lower abdomen which may extend to the lower legs and back. Most women begin having dysmenorrhea during adolescence, usually within four to five years of first menstrual period. Prostaglandins are chemicals that are formed in the lining of the uterus during menstruation. These prostaglandins cause muscle contractions in the uterus, which cause
Dysmenorrhea Treatment Market size and forecast, 2016-2026
Dysmenorrhea is a medical terminology used for menstrual pains in which the female encounters severe cramps in her lower abdomen which may extend to the lower legs and back. Most women begin having dysmenorrhea during adolescence, usually within four to five years of first menstrual period. Prostaglandins are chemicals that are formed in the lining of the uterus during menstruation. These prostaglandins cause muscle contractions in the uterus, which cause